{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:31:28Z","timestamp":1787232688538,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Antimicrobial resistance (AMR) is a global health concern. Cancer patients are 1.5\u20132 times more likely to be affected by AMR than other patient groups. This policy brief, informed by microbiological studies conducted at the Uganda Cancer Institute since 2014, presents key recommendations and implementation strategies for the management of bacterial infections in cancer patients in sub-Saharan Africa (SSA). Our recommendations include strengthening AMR surveillance, implementing context-specific infection prevention and control and antimicrobial stewardship programs, and raising awareness of AMR in cancer in the health sector and community in SSA. A collaborative multidisciplinary approach which includes infectious diseases expertise is required to effectively implement health policies and guidelines. Proactive and effective health policies which address AMR in cancer are critical in cancer centers in SSA.<\/jats:p>","DOI":"10.3389\/fphar.2026.1889223","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:15:46Z","timestamp":1787231746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The urgent need to integrate infectious diseases expertise into the management of cancer patients with infections in sub-Saharan Africa in the era of antimicrobial resistance: a policy brief"],"prefix":"10.3389","volume":"17","author":[{"given":"Margaret","family":"Lubwama","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gulleen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Internal Medicine, University of Minnesota","place":["Minneapolis, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sekyanzi","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benon","family":"Asiimwe","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhaji","family":"Njai","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Fourah Bay College and Department Microbiology, College of Medicine and Allied Health Sciences, University of Sierra Leone","place":["Freetown, Sierra Leone"]},{"name":"Koinadugu College","place":["Kabala, Sierra Leone"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Winter","sequence":"additional","affiliation":[{"name":"Department of Biosciences, School of Science and Technology, Nottingham Trent University","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Hoyles","sequence":"additional","affiliation":[{"name":"Department of Biosciences, School of Science and Technology, Nottingham Trent University","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nixon","family":"Niyonzima","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ddungu","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Kambugu","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Nakaganda","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute","place":["Kampala, Uganda"]},{"name":"Ananda Center for Cancer Research","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Kateete","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Phipps","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center","place":["Seattle, WA, United States"]},{"name":"Allergy and Infectious Diseases Division, Department of Medicine, University of Washington","place":["Seattle, WA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bwanga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12879-020-4886-2","article-title":"Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns","volume":"20","author":"Chinowaita","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e71976","DOI":"10.1002\/hsr2.71976","article-title":"Antimicrobial resistance in cancer care: challenge and path forward","volume":"9","author":"Edward","year":"2026","journal-title":"Health Science Reports"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00048-19","article-title":"Antimicrobial resistance surveillance in Low- and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries","volume":"33","author":"Gandra","year":"2020","journal-title":"Clin. Microbiology Reviews"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin. Microbiology Infection The Official Publication Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1001\/amajethics.2024.373","article-title":"How should we manage antimicrobial resistance in resource-limited settings?","volume":"26","author":"Gulleen","year":"2024","journal-title":"AMA Journal Ethics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"ofad508","DOI":"10.1093\/ofid\/ofad508","article-title":"Etiology of fever and associated outcomes among adults receiving chemotherapy for the treatment of solid tumors in Uganda","volume":"10","author":"Gulleen","year":"2023","journal-title":"Open Forum Infectious Diseases"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70495","DOI":"10.1002\/cam4.70495","article-title":"Burden of antimicrobial resistance in adult hospitalized patients with cancer: a multicenter analysis","volume":"13","author":"Gupta","year":"2024","journal-title":"Cancer Med."},{"key":"B9","volume-title":"University of Oxford. Global Bacterial Antimicrobial Resistance Burden Estimates 2019","year":"2022"},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob. Resistance Infection Control"},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2017.11.005","article-title":"Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data","volume":"120","author":"Lalami","year":"2017","journal-title":"Crit. Reviews Oncology\/hematology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3322\/caac.20124","article-title":"Oncologic emergencies: pathophysiology, presentation, diagnosis, and treatment","volume":"61","author":"Lewis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13104-019-4520-9","article-title":"Bacteremia in febrile cancer patients in Uganda","volume":"12","author":"Lubwama","year":"2019","journal-title":"BMC Res. Notes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ofae682","DOI":"10.1093\/ofid\/ofae682","article-title":"Etiology, risk factors, and outcomes of bacteremia in patients with hematologic malignancies and febrile neutropenia in Uganda","volume":"11","author":"Lubwama","year":"","journal-title":"Open Forum Infectious Diseases"},{"key":"B15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2147\/IDR.S442646","article-title":"CTX-M, TEM, and SHV genes in Escherichia coli, Klebsiella pneumoniae, and enterobacter spp isolated from hematologic cancer patients with bacteremia in Uganda","volume":"17","author":"Lubwama","year":"","journal-title":"Infect. Drug Resistance"},{"key":"B16","volume-title":"Uganda Clinical Guidelines 2023: National Guidelines for Management of Common Conditions","year":"2024"},{"key":"B17","unstructured":"National cancer control strategic plan\n          \n          \n          2026"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1049986","DOI":"10.3389\/fpubh.2023.1049986","article-title":"Emerging infectious disease outbreaks in Sub-Saharan Africa: learning from the past and present to be better prepared for future outbreaks","volume":"11","author":"Moyo","year":"2023","journal-title":"Front. Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijid.2018.09.012","article-title":"Bloodstream infections in oncology patients at red cross war memorial Children\u2019s hospital, cape town, from 2012 to 2014","volume":"77","author":"Mvalo","year":"2018","journal-title":"Int. Journal Infectious Diseases IJID Official Publication Int. Soc. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/s12879-024-09806-y","article-title":"Increasing trends of antibiotic resistance in Uganda: analysis of the national antimicrobial resistance surveillance data, 2018-2021","volume":"24","author":"Namubiru","year":"2024","journal-title":"BMC Infectious Diseases"},{"key":"B21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.21697","article-title":"Antibiotic resistance in the patient with cancer: escalating challenges and paths forward","volume":"71","author":"Nanayakkara","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.4102\/ajlm.v14i1.2816","article-title":"Bacterial agents and antibiotic resistance in febrile neutropaenia in Africa: a systematic review and meta-analysis","volume":"14","author":"Obadare","year":"2025","journal-title":"Afr. Journal Laboratory Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-319-04220-6_6","article-title":"Neutropenic fever and sepsis: evaluation and management","volume":"161","author":"Rolston","year":"2014","journal-title":"Cancer Treat. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/s2214-109x(23)00539-9","article-title":"The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis","volume":"12","author":"Sartorius","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"03007","DOI":"10.7189\/jogh.16.03007","article-title":"Strengthening healthcare systems to prevent antimicrobial resistance in LMICs: it is time to act","volume":"16","author":"Sorn","year":"2026","journal-title":"J. Global Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B27","unstructured":"Turkey cancer control programme\n          \n          \n          2026"},{"key":"B28","unstructured":"Addressing antimicrobial resistance in cancer care: a review of national cancer control plans and policy recommendations\n          \n          \n          2026"},{"key":"B29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/s1470-2045(03)01218-x","article-title":"Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment","volume":"4","author":"Vento","year":"2003","journal-title":"Lancet Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin. Infectious Diseases An Official Publication Infect. Dis. Soc. Am."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/clinids\/10.5.1048","article-title":"Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine","volume":"10","author":"West","year":"1988","journal-title":"Rev. Infectious Diseases"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0266919","DOI":"10.1371\/journal.pone.0266919","article-title":"Bacterial profile and antimicrobial susceptibility patterns in cancer patients","volume":"17","author":"Worku","year":"2022","journal-title":"PLoS One"},{"key":"B33","volume-title":"Drug-Resistant Infections: A Threat to Our Economic Future","year":"2017"},{"key":"B34","unstructured":"Draft updated global action plan on antimicrobial resistance\n          \n          \n          2026"},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4314\/ahs.v22i4.10","article-title":"Bloodstream infection in cancer patients; susceptibility profiles of the isolated pathogens, at Khartoum oncology hospital, Sudan","volume":"22","author":"Zain","year":"2022","journal-title":"Afr. Health Sciences"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1889223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:15:50Z","timestamp":1787231750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1889223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":35,"alternative-id":["10.3389\/fphar.2026.1889223"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1889223","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1889223"}}